The new Amass app is live. Ask in plain language, check every claim. Try it free

Skills & PromptsTrust-filtered grounded answer

Prompt

Trust-filtered grounded answer

Ask a clinical question; get an answer where every sentence is pinned to a high-quality, non-retracted paper — and anything the evidence can't support is refused, not fabricated.

See the prompt

New to Amass? Connect Amass to Claude first

9claims checked
2clinical questions
You getcsv2 files
Promptclinical-evidenceclaude

The prompt

Paste this into Claude

Clinical questionlecanemab efficacy and ARIA risk in early Alzheimer's
prompt
QUESTION: What does high-quality, non-retracted evidence say about lecanemab's efficacy and
ARIA risk in early Alzheimer's disease?

You have the Amass MCP connected (BiomedCore). Answer the QUESTION, but make every sentence
TRACEABLE — and refuse anything you cannot ground.

1. Pull a trust-filtered corpus. Call search_amass_biomedcore_records with:
     query = the key clinical terms from the QUESTION (strip punctuation/operators)
     minJournalQualityJufo = 2
     isRetracted = false
   (add minPublicationDate if the question implies recency). This returns up to `limit`
   domain-leading, non-retracted papers, each with an abstract — `limit` is 1–50 and defaults
   to the 10 this prompt uses.

2. Write the answer as a short list of CLAIM sentences. For EACH claim, it must be grounded in a
   specific returned abstract. Build a PER-CLAIM PROVENANCE TABLE with columns:
     Claim | Status | Source PMID | Journal | JuFo | Citations | Retracted? | Basis (abstract snippet)
   "Basis" must quote or closely track the abstract sentence that supports the claim. Numbers
   (percentages, hazard ratios, durations) must appear verbatim in that abstract — never rounded
   from memory, never invented.

3. REFUSE, don't guess. If a sub-question cannot be grounded in any returned JuFo>=2 abstract,
   add a row with Status = REFUSED and a Basis that says why (e.g. "no returned high-quality
   abstract reports this outcome"). If the high-quality evidence CONTRADICTS a premise in the
   question, mark Status = REFUSED (contradicted) and cite the contradicting record. Do NOT fill
   refused rows with plausible-sounding numbers.

4. NEGATIVE CONTROL (always include). Append two deliberately ungroundable sub-questions for this
   topic and show them being refused — e.g. a long-horizon outcome the trials never measured, and
   a stronger claim than the evidence supports (cure/reversal vs slowing). This demonstrates that
   the answer refuses rather than over-answers.

5. Then write the prose answer using ONLY the GROUNDED claims, each tagged with its PMID. End with:
   "Grounded claims: N. Refused (ungrounded/contradicted): M. Every grounded number above appears
   verbatim in the cited abstract; nothing was filled in from memory." Output the provenance
   table as a CSV.

Why not just ask the model?

A plain model answers a clinical question fluently and quietly invents the specifics — an ARIA-E rate, an APOE-homozygote risk, a hazard ratio — with no source and no quality gate.

  • Plain model: fluent prose, fabricated numbers, no provenance, no refusals.
  • Amass: a JuFo≥2, non-retracted corpus where every claim is pinned to an abstract — the ≈5-month slowing of decline (PMID 37295957), the 13.6% ARIA-E rate and 34.5% in APOE ε4 homozygotes (PMID 38730496) — and anything the corpus can't support is refused, not guessed.

Honest scope

The corpus is the top-10 JuFo≥2, non-retracted papers Amass returns for the query — a trust-gated sample, not an exhaustive review. Every claim is grounded in a returned abstract; a sub-question the corpus can't support is refused, not filled in. It grounds and cites clinical evidence; it is not medical advice, and a refusal marks where high-quality evidence is silent.

More from the library

Keep exploring

xlsx
14trials watched
Short nameSource idRegistryCopy of
Acute, 50/75 mg vs placeboNCT04072354ClinicalTrials.gov
↳ EUCTR2019-000470-36-BGEU CTRNCT04072354
Acute, 75/100 mg vs placeboNCT04092686ClinicalTrials.gov
competitive-intelligenceSkill

Watchlist Monitor

Name the trials, papers, approvals or drugs you need to follow; get one Excel board that re-reads them through Amass at every check and tells you exactly what changed: status, dates, enrollment, results posted, label revisions, retractions, new links.

pdf+1
196trials in scope
Landscape Monitor — page 1
competitive-intelligenceSkill

Landscape Monitor

Name a field; get it mapped across trials, papers, patents, drugs, genes and approvals into a landscape page with charts, a workbook and a one-page briefing, every record screened with its reason. Ask for an update later to see what is new and what changed.

csv
12targets scored
kinasekinase_family_chembl_leafsmall_molecule_tractabilityprotac_tractability
PLK1Other protein kinase PLK familyAdvanced Clinicalpredictive-only
WEE1Other protein kinase WEE familyAdvanced Clinicalpredictive-only
CDK1CMGC protein kinase CDK5 subfamilyAdvanced Clinicalpredictive-only
researchSkill

Target prioritization matrix

A general, interview-driven target-discovery workbench: name the biology and the modality you care about, and get back a scored table of candidate targets — druggability, essentiality, genetic constraint, curated safety, and the real number of drugs already targeting each — assembled from GeneCore intelligence and DrugCore/TrialCore/BiomedCore/PatentCore cross-links.

Run it yourself

Connect Amass to Claude and paste the prompt.

The connector takes about a minute to add, then this workflow runs on your own inputs.

Data
No training on your data
Hosting
EU-hosted, enterprise
Isolation
Tenant-isolated by architecture
Certification
ISO 27001, SOC 2, NIS2: in motion